No Data
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Teva Pharmaceutical Industries (NYSE:TEVA) Shareholder Returns Have Been Impressive, Earning 146% in 5 Years
Forecasting The Future: 6 Analyst Projections For Teva Pharmaceutical Indus
Teva Pharmaceutical Indus Analyst Ratings
BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Cuts Target Price to $20
